Xiangxue Pharmaceutical Co.,Ltd. (SZSE: 300147)
Health Care · Pharmaceuticals · CN
CN¥5.90
+4.98% today · -43.3% 1Y
Xiangxue Pharmaceutical Co.,Ltd. (SZSE: 300147) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $581.64M and employs 2,662 people.
Over the last twelve months the share price has lost 43.3%, trading between 5.03 and 11.37.
Tweenvest scores Xiangxue Pharmaceutical Co.,Ltd. across four factors: quality 41/100, value 42/100, growth 5/100. Its strongest factor is value.
300147 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $581.64M
- Revenue (TTM)
- $217.91M
- P/E
- —
- EPS
- -2.18
- Dividend yield
- —
- Beta (5Y)
- 0.53
- 52-week high
- CN¥11.37
- 52-week low
- CN¥5.03
- Avg volume (3M)
- —
- Shares outstanding
- 661.28M
- Employees
- 2,662
- Next earnings
- —
About Xiangxue Pharmaceutical Co.,Ltd.
Xiangxue Pharmaceutical Co., Ltd. is actively involved in the full pharmaceutical lifecycle within China, from scientific research and product development to sourcing, production, and market distribution. The company's product portfolio notably includes its branded Xiangxue antivirotic oral liquids. Beyond these pharmaceutical offerings, it also provides a variety of healthcare supplements and comprehensive wellness solutions, such as specialized food and beverage items. Xiangxue Pharmaceutical has forged a strategic alliance with 111, Inc., with the aim of advancing an "Internet + Medicine" framework tailored for China's traditional Chinese medicine industry. The firm was established in 1997 and its main operations are based in Guangzhou, China.
- ISIN
- CNE100000Y92
- Founded
- 1986
- Listed since
- Dec 15, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hefei Lifeon Pharmaceutical Co., Ltd.SZSE: 003020 | $587.23M | CN¥17.26 | +1.59% |
| Shanghai Xiao Fang Pharmaceutical Co.,Ltd.SHSE: 603207 | $585.90M | CN¥24.46 | +0.87% |
| Tibet Weixinkang Medicine Co., Ltd.SHSE: 603676 | $585.87M | CN¥9.09 | +2.71% |
| Jinhe Biotechnology CO., LTD.SZSE: 002688 | $585.82M | CN¥5.20 | +0.97% |
| Qianjiang Yongan Pharmaceutical Co., Ltd.SZSE: 002365 | $581.07M | CN¥13.48 | -2.53% |
| Middle East Pharmaceutical Industries CompanySASE: 4016 | $579.84M | SR62.20 | -3.12% |
| Xuanzhu Biopharmaceutical Co., Ltd.SEHK: 2575 | $579.19M | HK$8.78 | +6.75% |
| Zhejiang Yatai Pharmaceutical Co., Ltd.SZSE: 002370 | $573.61M | CN¥5.16 | +0.78% |
Figures last refreshed Oct 4, 2026.